TCV-309
TCV-309 is an antagonist for platelet activating factor (PAF) . TCV-309 improves the left ventricular function during ischemia-reperfusion (77.6% recover at 1 μM), protects the cardiac function[1].
Product Specifications
CAS Number
131311-25-6
UNSPSC
12352005
Target
Platelet-activating Factor Receptor (PAFR)
Type
Reference compound
Related Pathways
GPCR/G Protein
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/tcv-309.html
Smiles
CCC[N+]1=CC(C(N(CCC(NCCOC(N2CC3=C(C=CC=C3)CC2)=O)=O)C4=CC=CC=C4)=O)=CC(Br)=C1.[O-][N+]([O-])=O
Molecular Formula
C30H34BrN5O7
Molecular Weight
656.52
References & Citations
[1]Katoh S, et al., Role of platelet activating factor in ischaemia-reperfusion injury of isolated rabbit hearts: protective effect of a specific platelet activating factor antagonist, TCV-309. Cardiovasc Res. 1993 Aug;27 (8) :1430-4.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6274944-01 0.2 mL
ARHGEF1, NT (ARHGEF1, Rho guanine nucleotide exchange factor 1, 115kD guanine nucleotide exchange factor, Sub1.5) (Azide free) (HRP)
Sign In for Pricing
View Details MBS6274944-02 5x 0.2 mL
ARHGEF1, NT (ARHGEF1, Rho guanine nucleotide exchange factor 1, 115kD guanine nucleotide exchange factor, Sub1.5) (Azide free) (HRP)
Sign In for Pricing
View Details MR201760L3V 200 µL
Sftpa1 (BC061096) Mouse Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details